UNKNOWN VLOC PRODUCT
Report
- Report Number
- 1219930-2014-01125
- Event Type
- Injury
- Date Received
- December 5, 2014
- Report Date
- November 17, 2014
- Manufacturer
- COVIDIEN, FORMERLY US SURGICAL A DIVISON
- Product Code
- GAM
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CI
- Reporter Occupation
- OTHER
Narratives
(B)(4).
TAPIA, J., GUILOFF, N., LAGOS, I., SOLARI, C., & PIZARRO, K. (2014). BARBED SUTURE VERSUS VIRYL FOR THE VAGINAL CUFF CLOSURE IN TOTAL LAPAROSCOPIC. GYNECOLOGICAL SURGERY. CONFERENCE: 23RD ANNUAL CONGRESS OF THE EUROPEAN SOCIETY OF GYNAECOLOGICAL ENDOSCOPY, ESGE 2014 BRUSSELS BELGIUM, 11(1 SUPPL. 1), 132-133. RETRIEVED NOVEMBER 17, 2014. OUR AIM WAS TO DO A RETROSPECTIVE ANALYSIS OF THE INTRA AND POSTOPERATIVE COMPLICATIONS WITH THE USE OF THREE DIFFERENT TECHNIQUES TO CLOSE THE VAGINA IN TOTAL LAPAROSCOPIC HYSTERECTOMY (TLH) IN 92 WOMEN. THIS WAS A SERIES OF TLH OVER A THREE YEAR PERIOD (JANUARY 2011 TO DECEMBER 2013). IT INCLUDED 92 CONSECUTIVE WOMEN REQUIRING HYSTERECTOMY. THREE SUTURE TECHNIQUES FOR THE CLOSURE OF VAGINAL CUFF WERE REVISED: BARBED SUTURE (VLOCK) PERFORMED BY LAPAROSCOPY, VICRYL PERFORMED BY LAPAROSCOPY AND VICRYL PERFORMED VAGINALLY. INTRAOPERATIVE , EARLY (0-7 DAYS) AND LATE POSTOPERATIVE (7-30 DAYS) COMPLICATIONS WERE REGISTERED. WE USED T-TEST TO ASSESS FOR DIFFERENCES BETWEEN GROUPS. THE AVERAGE AGE OF PATIENTS WAS 47,6 YEARS, RANGE 30 TO 78. FOR THE CLOSURE OF THE VAGINAL CUFF, BARBED SUTURE WAS USED IN 39,1% (36) OF THE HYSTERECTOMIES. 52,2% (48) WERE IN THE GROUP OF VICRYL SUTURE PERFORMED VAGINALLY, AND 3,3% (3) WERE VICRYL SUTURE PERFORMED BY LAPAROSCOPY. NO INTRAOPERATIVE COMPLICATIONS RELATED TO THE SUTURE OCCURRED. THE LATE POSTOPERATIVE COMPLICATIONS WERE: 1 VAGINAL CUFF DEHISCENCE WHICH REQUIRED RE-SUTURING ON THE 16TH POST OPERATORY DAY IN BARBED SUTURE GROUP.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 788299 | UNKNOWN VLOC PRODUCT | UNKNOWN VLOC | GAM | COVIDIEN, FORMERLY US SURGICAL A DIVISON | UNKNOWN-VLOC | NOT AVAILABLE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |